Neural stem cells as tools for drug discovery: Novel platforms and approaches

Expert Opinion on Drug Discovery

Volumn 8, Issue 9, 2013, Pages 1083-1094

  Gorba, Thorsten ^a   Conti, Luciano ^b  

^a StemCells Inc   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cell based drug screening; Drug discovery; High throughput screening; IPS cells; Neural stem cells; Neurodegenerative diseases; Predictive toxicology; Psychiatric disorders; Screening platforms

Indexed keywords

NEW DRUG;

CELL CULTURE; CELL GROWTH; DRUG SCREENING; HIGH THROUGHPUT SCREENING; MONOLAYER CULTURE; NEURAL STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW;

EID: 84883044632     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2013.805199     Document Type: Review

References (97)

1. Rios C, Garbayo E, Gomez AL, et al. Stem cells and their contribution to tissue repair. Stem Cell Regener Med 2010;1:9-22
2. Smith AG. A glossary for stem-cell biology. Nature 2006;441(70974):1060-5
3. Conti L, Cattaneo E. Neural stem cell systems: Physiological players or in vitro entities? Nat Rev Neurosci 2010;11(3):176-87
4. Grskovic M, Javaherian A, Strulovici B, et al. Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 2011;10(12):915-29
5. Grabel L. Developmental origin of neural stem cells: The glial cell that could. Stem Cell Rev 2012;8(2):577-85
6. Malatesta P, Hartfuss E, G€otz M. Isolation of radial glial cells by fluorescent-activated cell sorting reveals a neuronal lineage. Development 2000;127(24):5253-63 (Pubitemid 32049182)
7. G€otz M, Huttner WB. The cell biology of neurogenesis. Nat Rev Mol Cell Bioly 2005;6(10):777-88 (Pubitemid 41726116)
8. Altman J. Are new neurons formed in the brains of adult mammals? Science 1962;135(3509):1127-8
9. Altman J, Das GD. Post-natal origin of microneurones in the rat brain. Nature 1965;207(5000):953-6
10. Reynolds BA, Tetzlaff W, Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 1992;12(11):4565-74
11. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992;255(5052):1707-10
12. Alvarez-Buylla A, Lim DA. For the long run: Maintaining germinal niches in the adult brain. Neuron 2004;41(5):683-6 (Pubitemid 38326831)
13. Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 2009;32:149-84
14. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282(5391):1145-7 (Pubitemid 28516247)
15. Zhang SC. Neural subtype specification from embryonic stem cells. Brain Pathol 2006;16(2):132-42
16. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126(4):663-76 (Pubitemid 44233629)
17. Kim JB, Zaehres H, Wu G, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008;454(7204):646-50
18. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131(5):861-72 (Pubitemid 350138099)
19. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318(5858):1917-20
20. Bellin M, Marchetto MC, Gage FH, et al Induced pluripotent stem cells: The new patient? Nat Rev Mol Cell Biol 2012;13(11):713-26
21. Liu GH, Suzuki K, Qu J, et al. Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 2011;8(6):688-94
22. Soldner F, Laganiere J, Cheng AW, et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011;146(2):318-31
23. Falk A, Koch P, Kesavan J, et al. Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons. PLoS One 2012;7(1):e29597
24. Reinhardt P, Glatza M, Hemmer K, et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS One 2013;8(3):e59252
25. Cacci E, Villa A, Parmar M, et al. Generation of human cortical neurons from a new immortal fetal neural stem cell line. Exp Cell Res 2007;313(3):588-601 (Pubitemid 46201811)
26. Cattaneo E, Conti L. Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J Neurosci Res 1998;53(2):223-34 (Pubitemid 28300128)
27. De Filippis L, Lamorte G, Snyder EY, et al. A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem Cells 2007;25(9):2312-21 (Pubitemid 47480490)
28. Martinez-Serrano A, Bjorklund A. Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci 1997;20(11):530-8 (Pubitemid 27459659)
29. Pastrana E, Silva-Vargas V, Doetsch F. Eyes wide open: A critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 2011;8(5):486-98
30. Chojnacki AK, Mak GK, Weiss S. Identity crisis for adult periventricular neural stem cells: Subventricular zone astrocytes, ependymal cells or both? Nat Rev Neurosci 2009;10(2):153-63
31. Capela A, Temple S. LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron 2002;35(5):865-75
32. Uchida N, Buck DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000;97(26):14720-5 (Pubitemid 32016642)
33. Chojnacki A, Weiss S. Production of neurons, astrocytes and oligodendrocytes from mammalian CNS stem cells. Nat Protoc 2008;3(6):935-40 (Pubitemid 351818681)
34. Ciccolini F. Identification of two distinct types of multipotent neural precursors that appear sequentially during CNS development. Mol Cell Neurosci 2001;17(5):895-907 (Pubitemid 32510537)
35. Machon O, Backman M, Krauss S, et al. The cellular fate of cortical progenitors is not maintained in neurosphere cultures. Mol Cell Neuroscience 2005;30(3):388-97 (Pubitemid 41416556)
36. Bez A, Corsini E, Curti D, et al. Neurosphere and neurosphere-forming cells: Morphological and ultrastructural characterization. Brain Res 2003;993(1-2):18-29 (Pubitemid 37464579)
37. Campos LS. Neurospheres: Insights into neural stem cell biology. J Neurosci Res 2004;78(6):761-9 (Pubitemid 39657564)
38. Palmer TD, Takahashi J, Gage FH. The adult rat hippocampus contains primordial neural stem cells. Mol Cell Neurosci 1997;8(6):389-404 (Pubitemid 127796477)
39. Conti L, Pollard SM, Gorba T, et al. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol 2005;3(9):e283
40. Elkabetz Y, Panagiotakos G, Al Shamy G, et al. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev 2008;22(2):152-65
41. Pollard SM, Conti L. Investigating radial glia in vitro. Prog Neurobiol 2007;83(1):53-67 (Pubitemid 47239229)
42. Biella G, Di Febo F, Goffredo D, et al. Differentiating embryonic stem-derived neural stem cells show a maturation-dependent pattern of voltage-gated sodium current expression and graded action potentials. Neuroscience 2007;149(1):38-52 (Pubitemid 47488659)
43. Goffredo D, Conti L, Di Febo F, et al. Setting the conditions for efficient, robust and reproducible generation of functionally active neurons from adult subventricular zone-derived neural stem cells. Cell Death Differ 2008;15(12):1847-56
44. Spiliotopoulos D, Goffredo D, Conti L, et al. An optimized experimental strategy for efficient conversion of embryonic stem (ES)-derived mouse neural stem (NS) cells into a nearly homogeneous mature neuronal population. Neurobiol Discov 2009;34(2):320-31
45. Hook L, Vives J, Fulton N, et al. Non-immortalized human neural stem (NS) cells as a scalable platform for cellular assays. Neurochem Int 2011;59(3):432-44
46. Pollard SM, Conti L, Sun Y, et al. Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb Cortex 2006;16(Suppl 1):i112-20
47. Sun Y, Pollard S, Conti L, et al. Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci 2008;38(2):245-58
48. Conti L, Crisafulli L, Caldera V, et al. REST controls self-renewal and tumorigenic competence of human glioblastoma cells. PLoS One 2012;7(6):e38486
49. Pollard SM, Yoshikawa K, Clarke ID, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009;4(6):568-80
50. Pollard S, Conti L, Smith A. Exploitation of adherent neural stem cells in basic and applied neurobiology. Regen Med 2006;1(1):111-18
51. Koch P, Opitz T, Steinbeck JA, et al. A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc Natl Acad Sci USA 2009;106(9):3225-30
52. Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011;473(7346):221-5
53. Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301(5634):805-9 (Pubitemid 36962615)
54. MacQueen GM, Campbell S, McEwen BS, et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003;100(3):1387-92 (Pubitemid 36184011)
55. Sahay A, Hen R. Adult hippocampal neurogenesis in depression. Nat Neurosci 2007;10(9):1110-15 (Pubitemid 47339960)
56. Allsopp TE, Bunnage ME, Fish PV. Small molecule modulation of stem cells in regenerative medicine: Recent applications and future direction. Med Chem Commun 2010;1(1):16-29
57. Li W, Jiang K, Ding S. Concise review: A chemical approach to control cell fate and function. Stem Cells 2012;30(1):61-8
58. Surmacz B, Fox H, Gutteridge A, et al. Directing differentiation of human embryonic stem cells toward anterior neural ectoderm using small molecules. Stem Cells 2012;30:1875-84
59. Lairson LL, Lyssiotis CA, Zhu S, et al. Small molecule-based approaches to adult stem cell therapies. Ann Rev Pharm Toxicol 2013;53:107-25
60. Breier JM, Radio NM, Mundy WR, et al. Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol Sci 2008;105(1):119-33
61. McLaren D, Gorba T, Marguerie de Rotrou A, et al. Automated large-scale culture and medium-throughput chemical screen for modulators of proliferation and viability of human induced pluripotent stem cell-derived neuroepithelial-like stem cells. J Biomol Screen 2013;18(3):258-68
62. Hsieh J, Nakashima K, Kuwabara T, et al. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 2004;101(47):16659-64 (Pubitemid 39557769)
63. Kim KJ, Wang J, Xu X, et al. A chemical genomics screen to discover genes that modulate neural stem cell differentiation. J Biomol Screen 2012;17(2):129-39
64. Wang J, Gallagher D, DeVito LM, et al. Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation. Cell Stem Cell 2012;11(1):23-35
65. Huang JK, Franklin RJ. Regenerative medicine in multiple sclerosis: Identifying pharmacological targets of adult neural stem cell differentiation. Neurochem Int 2011;59(3):329-32
66. Huang JK, Jarjour AA, Nait Oumesmar B, et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 2011;14(1):45-53
67. Haidet-Phillips AM, Hester ME, Miranda CJ, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 2011;29:824-8
68. Shaltouki A, Peng J, Liu Q, et al. Efficient generation of astrocytes from human pluripotent stem cells in defined conditions. Stem Cells 2013;31:941-52
69. H€oing S, Rudhard Y, Reinhardt P, et al. Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell based phenotypic assay. Cell Stem Cell 2012;11:620-32
70. Cecchelli R, Berezowski V, Lundquist S, et al. Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 2007;6:650-61 (Pubitemid 47202487)
71. Cucullo L, Hossain M, Rapp E, et al. Develoepment of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs. Epilepsia 2007;48:505-16 (Pubitemid 46365189)
72. Choi KD, Yu J, Kim SO, et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009;27(3):559-67
73. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3(8):711-15 (Pubitemid 39173511)
74. Schnabel J. Vaccines: Chasing the dream. Nature 2011;475(7355):S18-19
75. Radio NM, Mundy WR. Developmental neurotoxicity testing in vitro: Models for assessing chemical effects on neurite outgrowth. Neurotoxicology 2008;29(3):361-76
76. Schadt EE, Sachs A, Friend S. Embracing complexity, inching closer to reality. Sci STKE 2005;2005(295):pe40
77. Reaume AG. Drug repurposing through nonhypothesis driven phenotypic screening. Drug Discov Today 2011;4(3):85-8
78. Swinney DC, Anthony J. How were new medicines discovered? Nat Rev Drug Discov 2011;10(7):507-19
79. Eggert US. The why and how of phenotypic small-molecule screens. Nat Chem Biol 2013;9:206-9
80. Hu M, Schurdak ME, Puttfarcken PS, et al. High content screen microscopy analysis of A beta 1-42-induced neurite outgrowth reduction in rat primary cortical neurons: Neuroprotective effects of alpha 7 neuronal nicotinic acetylcholine receptor ligands. Brain Res 2007;1151:227-35 (Pubitemid 46709875)
81. Xu X, Lei Y, Luo J, et al. Prevention of beta-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle events. Stem Cell Res 2013;10(2):213-27
82. Thomas N. High-content screening: A decade of evolution. J Biom Screen 2010;15(1):1-9
83. Zock JM. Applications of high content screening in life science research. Comb Chem High Throughput Screen 2009;12(9):870-6
84. Daub A, Sharma P, Finkbeiner S. High-content screening of primary neurons: Ready for prime time. Curr Opin Neurobiol 2009;19(5):537-43
85. Li F, Yin Z, Jin G, et al. Chapter 17: Bioimage informatics for systems pharmacology. PLoS Comp Biol 2013;9(4):e1003043
86. Terstappen GC, Schlüpen C, Raggiaschi R, Gaviraghi G. Target deconvolution strategies in drug discovery. Nat Rev Drug Discov 2007;6:891-903 (Pubitemid 350042397)
87. Dunn DA, Apanovitch D, Follettie M. Taking a systems approach to the identification of novel therapeutic targets and biomarkers. Curr Pharm Biotechnol 2010;11(7):721-34
88. Hergenrother PJ, Palchaudhuri R. Transcript profiling and RNA interference as tools to identify small molecule mechanisms and therapeutic potential. ACS Chem Biol 2011;6:21-33
89. Kallos MS, Sen A, Behie LA. Large-scale expansion of mammalian neural stem cells: A review. Med Biol Eng Comput 2003;41(3):271-82 (Pubitemid 36701030)
90. Thomas RJ, Hope AD, Hourd P, et al. Automated, serum-free production of CTX0E03: A therapeutic clinical grade human neural stem cell line. Biotech Lett 2009;31(8):1167-72
91. Nguyen HN, Byers B, Cord B, et al LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptability to oxidative stress. Cell Stem Cell 2011;8:267-80
92. Kondo T, Asai M, Tsukita K, et al. Modeling Alzheimer's disease with iPSC reveals stress phenotypes associated with intracellular Ab and differential drug responsiveness. Cell Stem Cell 2013;12:1-10
93. Peng J, Liu Q, Rao MS, Zeng X. Using human pluripotent stem cell-derived dopaminergic neurons to evaluate candidate Parkinson's disease therapeutic agents in MPP+ and rotenone models. J Biomol Screen 2013;18:522-33
94. Yang YM, Gupta SK, Kim KJ, et al. A small molecule screen in stem cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 2013;12:1-14
95. Scannell JW, Blanckley A, Boldon H, et al. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 2012;1(11):191-200
96. Paul SM, Mytelka DS, Dunwiddie CT, et al. How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nat Rev Drug Discov 2010;9(3):203-14
97. Hyman SE. Revolution stalled. Sci Transl Med 2012;4(155):155-61